Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Review

Published on 13 Oct 2025

Treatment and prognosis of failure of first-line immunotherapy or recurrent autoimmune encephalitis patients with ofatumumab—a fully human anti-CD20 mAb

in Multiple Sclerosis and Neuroimmunology

Yajing Liu
Yanbo Zhang
Zhijiao Song
Shuanghao Feng
Tongxin Cao
Hui Bu

Frontiers in Neurology

doi 10.3389/fneur.2025.1671481

1,199 views

Systematic Review

Published on 10 Oct 2025

Effects of non-invasive brain stimulation on balance control in patients with multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Longtao Zhang
Yanxiao Sun
Zhihao Diao
Yifan Jiang
Yufei Hu
Yuxia Ma

Frontiers in Neurology

doi 10.3389/fneur.2025.1696343

2,126 views

Original Research

Published on 09 Oct 2025

Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study

in Multiple Sclerosis and Neuroimmunology

Gytis Makarevičius
Rasa Kizlaitienė
Gintaras Kaubrys
Nataša Giedraitienė

Frontiers in Neurology

doi 10.3389/fneur.2025.1635618

1,776 views
1 citation

Systematic Review

Published on 07 Oct 2025

Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis

in Multiple Sclerosis and Neuroimmunology

Zhuyuan Fan
Dan Liu
Guangwei Zhang
Xinlin Guo

Frontiers in Neurology

doi 10.3389/fneur.2025.1649429

2,401 views

Original Research

Published on 02 Oct 2025

The frequency of psoriasis in Australian multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Varitsara Mangkorntongsakul
Ariadna Fontes-Villalba
Turlough Montague
Olivia Charlton
Chun-Ting Justin Kwong
Helen Marie McGuire
Venkatesha Venkatesha
Geoffrey Herkes
Saxon Smith
John Parratt

Frontiers in Neurology

doi 10.3389/fneur.2025.1663015

1,869 views
1 citation

Editorial

Published on 30 Sep 2025

Editorial: Women in multiple sclerosis and neuroimmunology: from bench to bedside

in Multiple Sclerosis and Neuroimmunology

Jessy J. Alexander
Krista D. DiSano
Liliana Patrucco
Mireya Fernandez-Fournier

Frontiers in Neurology

doi 10.3389/fneur.2025.1677618

1,535 views

Original Research

Published on 30 Sep 2025

Evaluating the impact of task-sequencing on cognitive and motor performance in MS: PASAT and 3-minute walk test order effects

in Multiple Sclerosis and Neuroimmunology

Valentin Siegert
Laura J. Köhler
Lucas Schreff
Daniel Hamacher
Patrick Oschmann
Veit Rothhammer
Philipp M. Keune
Roy Müller

Frontiers in Neurology

doi 10.3389/fneur.2025.1654656

1,492 views

Policy and Practice Reviews

Published on 29 Sep 2025

Glial fibrillary acidic protein autoimmunity in reversible splenial lesion syndrome: diagnostic and therapeutic implications

in Multiple Sclerosis and Neuroimmunology

Lingling Lin
Xiang Li
Chao Quan
Jingzi Zhangbao
Hongmei Tan
Yi Wang
Siyuan Xu
Zhihao Dai

Frontiers in Neurology

doi 10.3389/fneur.2025.1650256

1,932 views

Original Research

Published on 29 Sep 2025

From demyelination to neurodegeneration in multiple sclerosis: reassessing the role of visual evoked potential P100-N145 amplitudes: a missing piece of the puzzle?

in Multiple Sclerosis and Neuroimmunology

Nurhan Kaya Tutar
Nilufer Kale

Frontiers in Neurology

doi 10.3389/fneur.2025.1649998

1,605 views

Hypothesis and Theory

Published on 25 Sep 2025

System-level hypothesis of dopamine imbalance in early multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Daniele Caligiore
Aurelia Schirripa
Monica Biggio

Frontiers in Neurology

doi 10.3389/fneur.2025.1653134

2,035 views

Brief Research Report

Published on 22 Sep 2025

Peripheral neuromodulation in spasticity-plus syndrome: effects of pulsed radiofrequency on tonic-painful disorders in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Luigi Di Lorenzo
Carmine D’Avanzo

Frontiers in Neurology

doi 10.3389/fneur.2025.1634960

1,894 views

Original Research

Published on 17 Sep 2025

Serum interleukin-40 increases in anti-AchR antibody-positive myasthenia gravis and correlates with disease activity

in Multiple Sclerosis and Neuroimmunology

Kun Jia
Yingzhe Shao
Taofeng Tan
Xuan Liu
Qiuxia Zhang
Ning Zhao
Li Yang

Frontiers in Neurology

doi 10.3389/fneur.2025.1680530

1,802 views

Brief Research Report

Published on 15 Sep 2025

Major depressive disorder in multiple sclerosis associated with differences in disease modifying therapy and demographics

in Multiple Sclerosis and Neuroimmunology

Nathanael J. Lee
Gavin Hui
C. William Pike
Kristin Galetta
Lucas B. Kipp
Jeffrey Dunn
Scheherazade Le
S. Sai Folmsbee

Frontiers in Neurology

doi 10.3389/fneur.2025.1663778

2,209 views

Original Research

Published on 15 Sep 2025

Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses

in Multiple Sclerosis and Neuroimmunology

Margherita Bellucci
Giovanna Capodivento
Federico Massa
Federica Bozzano
Giacomo Bavestrello
Elena Baroncelli
Corrado Cabona
Antonia Cagnetta
Angelo Schenone
Lucilla Nobbio

Frontiers in Neurology

doi 10.3389/fneur.2025.1659670

1,555 views

Original Research

Published on 02 Sep 2025

Autoimmune encephalitis in Latin America. Clinical features and outcomes in pediatric and adult populations: retrospective cohort of The REAL LABIC Project

in Multiple Sclerosis and Neuroimmunology

Miguel A. Vences
Christoper A. Alarcon Ruiz
Mary Marcela Araujo Chumacero
Diego Canales-Pichen
Victor Saquisela
Jesús Domínguez-Rojas
Donoband Melgarejo
Saúl Reyes-Niño
Cintia Johnston
Maricela García-Arellano

Frontiers in Neurology

doi 10.3389/fneur.2025.1647087

2,587 views

Original Research

Published on 28 Aug 2025

Aberrant lncRNA and mRNA expression in patients with anti-N-methyl-d-aspartate receptor encephalitis

in Multiple Sclerosis and Neuroimmunology

Xiaoyu Ma
Wenbo Guo
Zixuan Teng
Qingqing Yin
Chunjuan Wang
Pin Wang
Shougang Guo

Frontiers in Neurology

doi 10.3389/fneur.2025.1605982

1,432 views

Original Research

Published on 26 Aug 2025

Clinical features and prognosis of NMOSD patients with positive autoimmune antibodies

in Multiple Sclerosis and Neuroimmunology

Yutao Liu
Yang Liu
Han Yuan
Limei Wang

Frontiers in Neurology

doi 10.3389/fneur.2025.1634127

2,314 views

Correction

Published on 14 Aug 2025

Correction: Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study

in Multiple Sclerosis and Neuroimmunology

Rongrong Wang
Tengteng Zhang
Han Wang
Yao Ren
Runze Zhao
Gaopan Zhang
Guoxun Zhang
Xiongfei Zhao

Frontiers in Neurology

doi 10.3389/fneur.2025.1669440

982 views

Review

Published on 30 Jul 2025

Eukaryotic initiation factors: central factor associating mRNA translational plasticity during neuropathic pain progression

in Multiple Sclerosis and Neuroimmunology

Xinshuo Li
Haibo Zhan
Xindan Zhang
Jiayi Li
Xiangrui Li
Xihua Lu
Changhong Miao
Chunli Zhou
Zhen Zhang

Frontiers in Neurology

doi 10.3389/fneur.2025.1566205

2,105 views

Original Research

Published on 28 Jul 2025

Serum homocysteine levels predict poor recovery and relapse in first-attack myelin oligodendrocyte glycoprotein antibody disease

in Multiple Sclerosis and Neuroimmunology

Yanfei Li
Yanjie Jia

Frontiers in Neurology

doi 10.3389/fneur.2025.1619479

2,240 views
1 citation

Review

Published on 25 Jul 2025

Contemporary insights into neuroimmune interactions across development and aging

in Multiple Sclerosis and Neuroimmunology

Xin Yi Yeo
Yunseon Choi
Yeonhee Hong
Hyuk Nam Kwon
Sangyong Jung

Frontiers in Neurology

doi 10.3389/fneur.2025.1611124

2,980 views
1 citation

Original Research

Published on 18 Jul 2025

Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms

in Multiple Sclerosis and Neuroimmunology

Nikita A. van de Burgt
Laila Kulsvehagen
Marina Mané-Damas
Luc Lutz
Anne-Catherine Lecourt
Clara Monserrat
Anita M. Vinke
Cem İ. Küçükali
Shenghua Zong
Carolin Hoffmann

Frontiers in Neurology

doi 10.3389/fneur.2025.1593042

2,368 views
1 citation

Original Research

Published on 17 Jul 2025

Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study

in Multiple Sclerosis and Neuroimmunology

Rongrong Wang
Tengteng Zhang
Han Wang
Yao Ren
Runze Zhao
Gaopan Zhang
Guoxun Zhang
Xiongfei Zhao

Frontiers in Neurology

doi 10.3389/fneur.2025.1608802

1,596 views
1 citation

Original Research

Published on 15 Jul 2025

Mental health outcomes in pregnant women with relapsing-remitting multiple sclerosis: a longitudinal cohort study

in Multiple Sclerosis and Neuroimmunology

Lena Kristina Pfeffer
Caren Ramien
Anja Harrison
Kostas Patas
Kristina Grentzenberg
Stefanie Reinhardt
Andrea Mönch
Max Kaufmann
Stefan M. Gold
Christoph Heesen

Frontiers in Neurology

doi 10.3389/fneur.2025.1619021

1,635 views

1,177 articles

articles

Treatment and prognosis of failure of first-line immunotherapy or recurrent autoimmune encephalitis patients with ofatumumab—a fully human anti-CD20 mAb

Effects of non-invasive brain stimulation on balance control in patients with multiple sclerosis: a systematic review and meta-analysis

Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study

Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis

The frequency of psoriasis in Australian multiple sclerosis patients

Editorial: Women in multiple sclerosis and neuroimmunology: from bench to bedside

Evaluating the impact of task-sequencing on cognitive and motor performance in MS: PASAT and 3-minute walk test order effects

Glial fibrillary acidic protein autoimmunity in reversible splenial lesion syndrome: diagnostic and therapeutic implications

From demyelination to neurodegeneration in multiple sclerosis: reassessing the role of visual evoked potential P100-N145 amplitudes: a missing piece of the puzzle?

System-level hypothesis of dopamine imbalance in early multiple sclerosis

Peripheral neuromodulation in spasticity-plus syndrome: effects of pulsed radiofrequency on tonic-painful disorders in multiple sclerosis

Serum interleukin-40 increases in anti-AchR antibody-positive myasthenia gravis and correlates with disease activity

Major depressive disorder in multiple sclerosis associated with differences in disease modifying therapy and demographics

Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses

Autoimmune encephalitis in Latin America. Clinical features and outcomes in pediatric and adult populations: retrospective cohort of The REAL LABIC Project

Aberrant lncRNA and mRNA expression in patients with anti-N-methyl-d-aspartate receptor encephalitis

Clinical features and prognosis of NMOSD patients with positive autoimmune antibodies

Correction: Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study

Eukaryotic initiation factors: central factor associating mRNA translational plasticity during neuropathic pain progression

Serum homocysteine levels predict poor recovery and relapse in first-attack myelin oligodendrocyte glycoprotein antibody disease

Contemporary insights into neuroimmune interactions across development and aging

Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms

Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study

Mental health outcomes in pregnant women with relapsing-remitting multiple sclerosis: a longitudinal cohort study